# Takeda Pharmaceutical Company Limited - Inspection Records

Source: https://www.globalkeysolutions.net/companies/takeda-pharmaceutical-company-limited/0f6bd1ca-94a2-41f0-a8dd-1af20069e6cf

> Inspection records and compliance data for Takeda Pharmaceutical Company Limited in Yamaguchi, 743-0011. Access full analysis and detailed observations.

---

## Details

- Name: Takeda Pharmaceutical Company Limited
- FEI Number: 3004664162
- City: Yamaguchi
- State: 743-0011
- Country Name: United States
- Address Line 1: Hikari
- Zip Code: Japan

## Related Documents

- [483 - Takeda Pharmaceutical Company Limited - 2023-11-06](https://www.globalkeysolutions.net/records/483/takeda-pharmaceutical-company-limited/9830bf69-579a-4bc0-bf7c-8ad2b78a6e53) — source: FDA, date: November 6, 2023
- [FDA Inspection 1224917 - Takeda Pharmaceutical Company Limited - 2023-11-06](https://www.globalkeysolutions.net/records/fda_inspections/takeda-pharmaceutical-company-limited/01fa4df9-a921-4e9e-be5f-bd7dcb845d86) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 6, 2023
- [483 - Takeda Pharmaceutical Company Limited - 2023-11-01](https://www.globalkeysolutions.net/records/483/takeda-pharmaceutical-company-limited/1896dda4-c7e8-4da9-b91a-daba1da128bc) — source: FDA, date: November 1, 2023
- [483 - Takeda Pharmaceutical Company Limited - 2023-05-24](https://www.globalkeysolutions.net/records/483/takeda-pharmaceutical-company-limited/ac78eb79-a4fa-40e6-a809-4bde4790ca58) — source: FDA, date: May 24, 2023
- [483 - Takeda Pharmaceutical Company Limited - 2021-07-19](https://www.globalkeysolutions.net/records/483/takeda-pharmaceutical-company-limited/116551bc-ee0b-45cf-ba4f-c6c4be7fe3d5) — source: FDA, date: July 19, 2021
- [483 - Takeda Pharmaceutical Company Limited - 2021-07-19](https://www.globalkeysolutions.net/records/483/takeda-pharmaceutical-company-limited/d7328c43-e92f-449d-bccf-293394b50bdc) — source: FDA, date: July 19, 2021
- [FDA Inspection 1148832 - Takeda Pharmaceutical Company Limited - 2021-07-19](https://www.globalkeysolutions.net/records/fda_inspections/takeda-pharmaceutical-company-limited/8bfab003-8b37-4dbd-9140-436b4717175e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2021
- [483 - Takeda Pharmaceutical Company Limited - 2019-11-26](https://www.globalkeysolutions.net/records/483/takeda-pharmaceutical-company-limited/58fc4bcb-d16e-4868-88eb-9a01737e1cc2) — source: FDA, date: November 26, 2019
- [483 - Takeda Pharmaceutical Company Limited - 2019-11-26](https://www.globalkeysolutions.net/records/483/takeda-pharmaceutical-company-limited/dc0ab72d-608b-4770-b885-4d26b8d7b7cf) — source: FDA, date: November 26, 2019
- [FDA Inspection 1111495 - Takeda Pharmaceutical Company Limited - 2019-11-26](https://www.globalkeysolutions.net/records/fda_inspections/takeda-pharmaceutical-company-limited/81193b1d-47fb-46c4-861a-52550748864c) — classification: Official Action Indicated (OAI), source: FDA, date: November 26, 2019
- [FDA Inspection 1033814 - Takeda Pharmaceutical Company Limited - 2017-11-07](https://www.globalkeysolutions.net/records/fda_inspections/takeda-pharmaceutical-company-limited/61a97094-4c3e-4a7f-97cb-253122c98060) — classification: No Action Indicated (NAI), source: FDA, date: November 7, 2017
- [FDA Inspection 951603 - Takeda Pharmaceutical Company Limited - 2015-10-30](https://www.globalkeysolutions.net/records/fda_inspections/takeda-pharmaceutical-company-limited/e5029390-61e2-4731-be3f-4ada0876fcc9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 30, 2015
- [FDA Inspection 851370 - Takeda Pharmaceutical Company Limited - 2013-09-18](https://www.globalkeysolutions.net/records/fda_inspections/takeda-pharmaceutical-company-limited/276ee3c2-f814-4f6d-8b57-e8a020931252) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 18, 2013
- [FDA Inspection 793421 - Takeda Pharmaceutical Company Limited - 2012-07-20](https://www.globalkeysolutions.net/records/fda_inspections/takeda-pharmaceutical-company-limited/1d8213eb-9f1f-4141-b2e3-1771a7068d5a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 20, 2012
- [FDA Inspection 748712 - Takeda Pharmaceutical Company Limited - 2011-09-29](https://www.globalkeysolutions.net/records/fda_inspections/takeda-pharmaceutical-company-limited/360946e9-4555-4b46-9e59-80792fde9d41) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2011
- [FDA Inspection 682751 - Takeda Pharmaceutical Company Limited - 2010-09-24](https://www.globalkeysolutions.net/records/fda_inspections/takeda-pharmaceutical-company-limited/cfcd5eab-ca82-4d27-a149-5baeabc589fe) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2010

## Related Companies

- [Torrent Pharmaceuticals Limited](https://www.globalkeysolutions.net/companies/torrent-pharmaceuticals-limited/801e26ba-26ed-40ab-84c9-d4ee2e24e42e)
- [AstraZeneca Pharmaceuticals LP](https://www.globalkeysolutions.net/companies/astrazeneca-pharmaceuticals-lp/6f9abb75-9352-43df-b761-026089396fa3)
- [EUGIA Pharma Specialities Limited](https://www.globalkeysolutions.net/companies/eugia-pharma-specialities-limited/c9c73721-7ca2-4457-89c9-f1001123e141)
- [Torrent Pharmaceuticals Limited](https://www.globalkeysolutions.net/companies/torrent-pharmaceuticals-limited/7d8d0f1a-2012-47a6-99c8-10c2953c39af)
- [Biocon Biologics Limited](https://www.globalkeysolutions.net/companies/biocon-biologics-limited/d4e5402d-7d48-48ee-911b-8a78bfb97a67)
- [Gland Pharma Limited](https://www.globalkeysolutions.net/companies/gland-pharma-limited/dd730d79-1c97-4fb0-b717-c0ebd71a5b3f)
- [Biological E. Limited](https://www.globalkeysolutions.net/companies/biological-e-limited/a02640a2-3dc0-448e-9a4f-df7e189939e4)
- [NerPharMa S.r.l.](https://www.globalkeysolutions.net/companies/nerpharma-srl/12f11f8a-e70e-4598-807c-a1571bab0391)
- [Cipla, Ltd.](https://www.globalkeysolutions.net/companies/cipla-ltd/f726d9c8-4fe7-456e-848c-f9ef86f00e4f)
- [Sumitomo Dainippon Pharma Co., Ltd.](https://www.globalkeysolutions.net/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/michele-perry-williams/80741e95-8df3-41c9-b9b8-499fcb97921d)
- [David J. Gomes](https://www.globalkeysolutions.net/people/david-j-gomes/dc3d1557-3bbc-4ed6-85fc-84b3462715c1)
- [Steven M. Weinman](https://www.globalkeysolutions.net/people/steven-m-weinman/66ffc074-e34a-4b53-a525-0d4a25c6a220)
- [Ileana Barreto-Petit](https://www.globalkeysolutions.net/people/ileana-barreto-petit/e5c865ac-14a2-47d4-954b-464a865e8684)
- [Vincent Thomas](https://www.globalkeysolutions.net/people/vincent-thomas/0925480c-5d8c-411f-86ee-5e4b924f8c12)
- [Quality System Specialist](https://www.globalkeysolutions.net/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)